Investors

 

Click here to access PDF versions of the press releases.

Flamel Technologies - Press Releases
Release year: 2014 | 2013 | 2012


October 21, 2014
Flamel Technologies to Report Third Quarter of Fiscal Year 2014 Results

September 29, 2014
Flamel Technologies Announces Positive Results of First-in-Man Clinical Trial With LiquiTime(R) Ibuprofen

September 11, 2014
Flamel Technologies Announces Plan to Appoint New VP of R&D

August 04, 2014
Flamel Notified of FDA Communication to Unapproved Manufacturers of Neostigmine Methylsulfate

July 29, 2014
Flamel Technologies Announces Second Quarter of Fiscal Year 2014 Results

July 22, 2014
Flamel Technologies to Report Second Quarter of Fiscal Year 2014 Results

July 02, 2014
Flamel Technologies Announces Results of 2014 Annual Meeting

June 30, 2014
Flamel Technologies Announces FDA Approval of VAZCULEP

June 25, 2014
Flamel Technologies Announces Positive Preclinical Results For Its Once-a-Week Formulation of Exenatide

June 16, 2014
Flamel Technologies Receives Class 1 Response Designation for Second NDA

June 05, 2014
Flamel Technologies Announces Intent to Resubmit Second NDA

May 12, 2014
Flamel Technologies Announces First Quarter of Fiscal Year 2014 Results

May 02, 2014
Flamel Technologies to Report First Quarter of Fiscal Year 2014 Results

April 29, 2014
Flamel Technologies Announces Receipt of Complete Response Letter From FDA Citing Issues at the Facility of the Supplier of the Active Ingredient

April 07, 2014
Flamel Technologies Announces Positive Results of a First-in-Man Clinical Trial With Micropump Sodium Oxybate

March 25, 2014
Flamel Technologies Announces Fourth Quarter and Full Year 2013 Results

March 17, 2014
Flamel Technologies to Report Fourth Quarter and Fiscal Year 2013 Results and Conference Call

March 07, 2014
Flamel Technologies, S.A. Announces Pricing of Public Offering of American Depositary Shares

March 06, 2014
Flamel Technologies, S.A. Announces Proposed Underwritten Public Offering of American Depositary Shares